METHODS OF IMMORTALIZING PRIMARY RESTING T CELLS BY CRISPR/DCAS9-BASED EPIGENETIC MODIFIERS AND TRANSCRIPTIONAL ACTIVATORS
US20260092294A1 · Application publication visible
immortal.lifeExplore source-linked longevity patent families and topic connections associated with the applicant name City University of Hong Kong.
This independent page groups EPO bibliographic records in which this name appears as an applicant or assignee. It is not a corporate profile, ownership opinion, portfolio valuation or ranking.
US20260092294A1 · Application publication visible